Skip to main content
SpringerLink
Log in

Etanercept increases risk of IBD in children with arthritis

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • van Straalen JW, et al. Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use. Rheumatology : 11 Sep 2021. Available from: URL: http://doi.org/10.1093/rheumatology/keab678

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Etanercept increases risk of IBD in children with arthritis. Reactions Weekly 1874, 7 (2021). https://doi.org/10.1007/s40278-021-02664-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-02664-y

Search

Navigation